<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Freiburg_Labjournals_SurChem_July skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Freiburg/Labjournals/SurChem/July</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>&quot;&quot;</TITLE></P><DIV id="header"><DIV id="naviconwrapper"><DIV id="naviconbar"><DIV id="navicons"><UL><LI id="home"><A href="https://2015.igem.org/Team:Freiburg/Home">Home</A></LI><LI id="project"><A href="https://2015.igem.org/Team:Freiburg/Project/Overview">Project</A></LI><LI id="team"><A href="https://2015.igem.org/Team:Freiburg/Team">Team</A></LI><LI id="results"><A href="https://2015.igem.org/Team:Freiburg/Results">Results</A></LI><LI id="policy" style="font-size:11px"><A href="https://2015.igem.org/Team:Freiburg/Practices">Human Practice</A></LI><LI id="notebook"><A href="https://2015.igem.org/Team:Freiburg/Notebook">Notebook</A></LI></UL></DIV></DIV></DIV><DIV id="navtextwrapper"><DIV id="navtext"><UL id="project-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/Overview">Introduction</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/System">Overview</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Design">Diagnostics today</A></LI><LI><A class="navsub1 subsubmenu" href="#">The DiaCHIP</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/DNA_Engineering">DNA Engineering</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Cellfree_Expression">Cell-Free Expression</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Protein_Purification">Protein Purification</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Surface_Chemistry">Surface Chemistry</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/iRIf">Optical Detection</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/Future_Directions">Outlook</A></LI><UL id="team-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Team">Members</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Attributions">Acknowledgements</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Partners">Partners</A></LI></UL><UL id="results-sub"><LI><A class="navsub1 subsubmenu" href="#">The DiaCHIP</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results">Main Results</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Diagnostics">Diagnostics</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Own_Device">Our Device</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Immobilization">DNA Array</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Cellfree">Cell-Free Expression</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Surface">Binding on Surface</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Modeling">Modeling</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Parts">BioBricks</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Collaborations">Collaborations</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/InterLab_Study">Interlab Study</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Achievements">Achievements</A></LI><UL id="policy-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Science_Fair">Science Fair</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Theater_Project">Theater Project</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Public_Opinion">Public Opinion</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/College">College Talk</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Ethics">Ethics</A></LI></UL><UL id="notebook-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Labjournals">Labjournals</A></LI><LI><A class="navsub1 subsubmenu" href="#">Techniques</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Classic_vs_Gibson">Gibson</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Coli_Strains">E.coli Strains</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Protocols">Protocols</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Materials">Materials</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Safety">Safety</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Wikimigration">Wiki-Tricks</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Glossary">Glossary</A></LI></DIV></DIV></DIV><DIV class="clearfix" id="smallnav"><UL class="clearfix"><LI id="home_small"><A href="https://2015.igem.org/Team:Freiburg/Home">Home</A></LI><LI id="project_small"><A href="https://2015.igem.org/Team:Freiburg/Project/Overview">Project</A></LI><LI id="results_small"><A href="https://2015.igem.org/Team:Freiburg/Results">Results</A></LI><LI id="team_small"><A href="https://2015.igem.org/Team:Freiburg/Team">Team</A></LI><LI id="policy_small"><A href="https://2015.igem.org/Team:Freiburg/Practices">Practice</A></LI><LI id="notebook_small"><A href="https://2015.igem.org/Team:Freiburg/Notebook">Notebook</A></LI></UL><A href="#" id="pull">Menu</A></DIV><DIV class="content_background_wrapper"><DIV class="central_position_wrap"><DIV class="page_content"><DIV class="button_back"><A style="color:#FFF" href="https://2015.igem.org/Team:Freiburg/Labjournals#surchem_lab">&lt;&lt; Back</A></DIV><DIV class="content_box"><H1 class="sectionedit1">Labjournal Surchem July</H1><H2 class="sectionedit2">Experiment 39b: PDITC iRIf slides for measurement with PhyA</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> preparing 4 iRIf PDITC slides for measurement</DIV></LI><LI class="level1"><DIV class="li"> spot PhyA on 2 slides</DIV></LI></UL></DIV><H3 class="sectionedit3">2015.07.30</H3><H4>Experiment/protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 4 PDITC iRIf slides were prepared according to protocol</DIV></LI><LI class="level1"><DIV class="li"> plasma activation for 5 min at 80 L/h</DIV></LI><LI class="level1"><DIV class="li"> slides were incubated in APTES for 30 min</DIV></LI><LI class="level1"><DIV class="li"> slides were incubated in PDITC for 2 h</DIV></LI><LI class="level1"><DIV class="li"> slides were stored o/n in desiccator </DIV></LI></UL></DIV><H3 class="sectionedit4">2015.07.31</H3><H4>Experiment/protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> for storage until Sunday 02.08.2015 the slides were taken out of the desiccator and put in a slideholder under N<SUB>2</SUB>-atmosphere at 4 °C</DIV></LI></UL></DIV><H3 class="sectionedit5">2015.08.02</H3><DIV class="level3"><UL><LI class="level1"><DIV class="li"> 3 µL of samples (1-3,6) and controls (GFP,bBSA) were spotted and incubated o/n at 4 °C. For samples 4-5 and 10-11 4 µl were spotted. </DIV></LI></UL><P>
spotting pattern:
</P><DIV class="table sectionedit6"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Elution no. </TH><TH class="col3"> Concentration </TH><TH class="col4"> Antibody </TH><TH class="col5"> AB-conc.[µg/ml] </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1"> Phy A </TD><TD class="col2"> 2 </TD><TD class="col3"> 6.6 mg/ml </TD><TD class="col5"> 5 µg/ml </TD></TR><TR class="row2"><TD class="col0"> 3 </TD><TD class="col1"> Phy A </TD><TD class="col2"> 3 </TD><TD class="col3"> 2.3. mg/ml </TD><TD class="col5"> 5 µg/ml </TD></TR><TR class="row3"><TD class="col0"> 4-5 </TD><TD class="col1"> Promega 104 </TD><TD class="col4"> anti-tYFP </TD><TD class="col5"> 20 </TD></TR><TR class="row4"><TD class="col0"> 6 </TD><TD class="col1"> rabbit AB (anti-HCV) </TD><TD class="col3"> 1 mg/mL </TD><TD class="col4"> anti-rabbit </TD><TD class="col5"> 20 </TD></TR><TR class="row5"><TD class="col0"> 7 </TD><TD class="col1"> Max GFP </TD><TD class="col3"> 1.0 mg/mL </TD><TD class="col4"> a-GFP (goat;biotinylated)</TD><TD class="col5"> 5 </TD></TR><TR class="row6"><TD class="col0"> 8 </TD><TD class="col1"> His-GFP Lysate </TD><TD class="col4"> a-GFP (goat;biotinylated)</TD><TD class="col5"> 5 </TD></TR><TR class="row7"><TD class="col0"> 9 </TD><TD class="col1"> bBSA </TD><TD class="col3"> 0.1 mg/mL </TD><TD class="col4"> Strep-Cy5 </TD><TD class="col5"> 10 </TD></TR><TR class="row8"><TD class="col0"> 10-11 </TD><TD class="col1">Promega 104 + feed </TD><TD class="col4"> anti-tYFP </TD><TD class="col5"> 20 </TD></TR><TR class="row9"><TD class="col4">anti-His (mouse)</TD><TD class="col5">20</TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit7">2015.08.03</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> protein solution was removed with pipette and spots were blocked 2x 5 min with BSA 10 mg/ml in PBS</DIV></LI><LI class="level1"><DIV class="li"> slides were blocked in 10 mg/mL BSA in PBS for 30 min</DIV></LI><LI class="level1"><DIV class="li"> slides were washed in PBS for 10 min</DIV></LI><LI class="level1"><DIV class="li"> slides were washed 2x in diluted PBS 1/10 for 10 min</DIV></LI><LI class="level1"><DIV class="li"> slides were dried with wafer gun and measured in iRIf</DIV></LI></UL></DIV><H4>Measurement</H4><H5>Slide 1</H5><DIV class="level5"><DIV class="table sectionedit8"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">80</TD><TD class="col3">940</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">45</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-GFP(goat;biotinylated)</TD><TD class="col1">4</TD><TD class="col2">25</TD><TD class="col3">720</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-tYFP (rabbit)</TD><TD class="col1">6</TD><TD class="col2">15</TD><TD class="col3">1200</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row7"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-PhyA (rabbit)</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Rabbit </TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">StrepCy5 </TD><TD class="col1">12</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row13"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV></DIV><H5>slide 2</H5><DIV class="level5"><DIV class="table sectionedit9"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">80</TD><TD class="col3">940</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">45</TD><TD class="col3">500</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-GFP(goat;biotinylated)</TD><TD class="col1">4</TD><TD class="col2">25</TD><TD class="col3">720</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-tYFP (rabbit)</TD><TD class="col1">6</TD><TD class="col2">15</TD><TD class="col3">1200</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row7"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-PhyA (rabbit, N-terminal)</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Rabbit </TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">15 ug/ml</TD></TR><TR class="row11"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">StrepCy5 </TD><TD class="col1">12</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row13"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><UL><LI class="level1"><DIV class="li"> another anti-Phy was used, because the one which was used in the first measurement was empty and also Phillip told us, that this one should bind better</DIV></LI></UL></DIV><H4>Results</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> Binding of anti-phyA to phyA was not observed in RIfs</DIV></LI><LI class="level1"><DIV class="li"> much of the protein was washed away from the spotted spot. </DIV></LI><LI class="level2"><DIV class="li"> We have to take lower concentrations for spotting (100-400 ug/ml)</DIV></LI></UL><LI class="level1"><DIV class="li"> no Anti-tYFP to tYFP binding could be detected</DIV></LI><LI class="level2"><DIV class="li"> to few tYFP on the slides because all proteins in Lysate bind to PDITC</DIV></LI><LI class="level2"><DIV class="li"> should use specific surface (e.g. Ni-NTA, Halo) next time, where only tYFP binds </DIV></LI><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 303: Inverted QP during initial buffer step: Shows that already much of the PhyA is flushed away from the spot</DIV></DIV></DIV></DIV><H2 class="sectionedit10">Experiment 39a: PDITC iRIf slides for measurement with purified antigens</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> preparing 4 iRIf PDITC slides for measurement</DIV></LI><LI class="level1"><DIV class="li"> spot antigens on 2 slides</DIV></LI></UL></DIV><H3 class="sectionedit11">2015.07.30</H3><H4>Experiment/protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 4 PDITC iRIf slides were prepared according to protocol</DIV></LI><LI class="level1"><DIV class="li"> plasma activation for 5 min at 80 L/h</DIV></LI><LI class="level1"><DIV class="li"> slides were incubated in APTES for 30 min</DIV></LI><LI class="level1"><DIV class="li"> slides were incubated in PDITC for 2 h</DIV></LI><LI class="level1"><DIV class="li"> 4 µL of antigens and bBSA were spotted and incubated o/n at 4 °C. For GFP Spot7 was 4 µl and spot8 was 3 µl</DIV></LI><LI class="level1"><DIV class="li"> in contrast to Experiment 37a the antigens of Tetanus (11) and Salmonella (15) were heatshocked before spotting.</DIV></LI></UL><P>
spotting pattern:
</P><DIV class="table sectionedit12"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Elution no. </TH><TH class="col3"> Concentration </TH><TH class="col4"> Antibody </TH><TH class="col5"> AB-conc.[µg/ml] </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1"> HIV(17) </TD><TD class="col2"> 1 </TD><TD class="col3 rightalign">  1.0 mg/mL?? </TD><TD class="col4"> gp41 DDX1306 </TD><TD class="col5"> 20 </TD></TR><TR class="row2"><TD class="col0"> 3-4 </TD><TD class="col1"> HCV(10) </TD><TD class="col2"> 1 </TD><TD class="col3 rightalign">  0.74 mg/mL?? </TD><TD class="col5"> 20 </TD></TR><TR class="row3"><TD class="col0"> 5-6 </TD><TD class="col1"> Tetanus(11) </TD><TD class="col2"> 1 </TD><TD class="col3 rightalign">  3.75 mg/mL?? </TD><TD class="col4">HYB 278-01 </TD><TD class="col5"> 20 </TD></TR><TR class="row4"><TD class="col0"> 7-8 </TD><TD class="col1"> GFP </TD><TD class="col3 rightalign">  1.0 mg/mL </TD><TD class="col4"> a-GFP (goat;biotinylated)</TD><TD class="col5"> 5 </TD></TR><TR class="row5"><TD class="col0"> 9 </TD><TD class="col1"> bBSA </TD><TD class="col3 rightalign">  0.1 mg/mL </TD><TD class="col4">Strep-Cy5 </TD><TD class="col5"> (Strep-Cy5) 10 </TD></TR><TR class="row6"><TD class="col0"> 10-11 </TD><TD class="col1"> Salmonella(15) </TD><TD class="col2"> 2 </TD><TD class="col3 rightalign">  6.7 mg/mL </TD><TD class="col4"> a-Salmonella-(pIG15_1301)</TD><TD class="col5"> 100 </TD></TR><TR class="row7"><TD class="col4">anti-His (mouse)</TD><TD class="col5">20</TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit13">2015.07.31</H3><H4>Experiment/protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> spots were blocked 2x 5 min with PDITC blocking solution</DIV></LI><LI class="level1"><DIV class="li"> slides were blocked in 10 mg/mL BSA in PBS for 30 min</DIV></LI><LI class="level1"><DIV class="li"> slides were washed in PBS for 10 min</DIV></LI><LI class="level1"><DIV class="li"> slides were washed in diluted PBS 2x 10 min</DIV></LI><LI class="level1"><DIV class="li"> slides were stored in Petri dish at 4 °C (humid atmosphere) until they could be measured in iRIf</DIV></LI></UL></DIV><H4>Measurement</H4><DIV class="level4"><P>
Flush protocol (Slide 208):
</P><DIV class="table sectionedit14"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">80</TD><TD class="col3">940</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">45</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-GFP(goat;biotinylated)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-HIV (monoclonal)</TD><TD class="col1">6</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row7"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-HCV (monoclonal)</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Tetanus (monoclonal)</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row11"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Anti-HIV (polyclonall)</TD><TD class="col1">12</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row13"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">Anti-HCV (polyclonal)</TD><TD class="col1">14</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row15"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row16"><TD class="col0">Anti-Salmonella (1301 Elu1)</TD><TD class="col1">16</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1:3</TD></TR><TR class="row17"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">17</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row18"><TD class="col0" colspan="4">….further steps were skipped</TD></TR></TBODY></TABLE></DIV><P>
For second slide flush protocol was changed→ added anti-His step and further dilutions of anti-Salmonella (but threw out a-HIV/a-HCV/anti-Tet)
Flush protocol (Slide 12):
</P><DIV class="table sectionedit15"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">600</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-GFP(goat;biotinylated)</TD><TD class="col1">4</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-His </TD><TD class="col1">6</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row7"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-Salm (Elu 3)</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1:5</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Salm (Elu 3)</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:2</TD></TR><TR class="row11"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Anti-Salm (Elu 1)</TD><TD class="col1">12</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">1:10</TD></TR><TR class="row13"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">Anti-Salm (Elu 1)</TD><TD class="col1">14</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1:3</TD></TR><TR class="row15"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row16"><TD class="col0">StrepCy5</TD><TD class="col1">16</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row17"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">17</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> Anti-His at least confirmed that something with a His-Tag is within the HIV and HCV spots (see binding curves of slide 12).</DIV></LI></UL><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Binding curves; flushing with anti-Salmonella lysate screwed up the measurement → protocol only to this step </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 208: Selection of ROIs: As can be seen we faced some problems during that measurement ;) </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12: Binding curves </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 12: Selection of ROIs </DIV></DIV></DIV></DIV><H2 class="sectionedit16">Experiment 38: Measurement of different GFPs with NanoDrop</H2><H3 class="sectionedit17">2015.07.29</H3><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> determine exact GFP concentration of used stock solution</DIV></LI></UL></DIV><H4>Experiment/protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> measured concentration of GFP from different sources via NanoDrop</DIV></LI><LI class="level1"><DIV class="li"> determined absorption at 488 nm of different GFP solutions and calculated concentration</DIV></LI><LI class="level1"><DIV class="li"> extinction coefficient EGFP ε = 55000 M<SUP>-1</SUP>cm<SUP>-1</SUP></DIV></LI><LI class="level1"><DIV class="li"> layer thickness d= 1 mm</DIV></LI><LI class="level1"><DIV class="li"> M(GFP)= 26900 g/mol</DIV></LI></UL></DIV><H4>Results</H4><DIV class="level4"><P>
This measurement:
</P><DIV class="table sectionedit18"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> GFP </TH><TH class="col1"> concentration [mg/ml] </TH><TH class="col2"> error [mg/ml] </TH></TR><TR class="row1"><TD class="col0">Max GFP</TD><TD class="col1">0.88</TD><TD class="col2">0.053 (6%)</TD></TR><TR class="row2"><TD class="col0">Lysate HisGFP</TD><TD class="col1">0.81</TD><TD class="col2">0.051 (6%)</TD></TR><TR class="row3"><TD class="col0">Lysate noTag GFP</TD><TD class="col1">1.25</TD><TD class="col2">0.039 (3%)</TD></TR><TR class="row4"><TD class="col0">Weber GFP 8.6</TD><TD class="col1">4.05</TD><TD class="col2">0.204(5%)</TD></TR><TR class="row5"><TD class="col0">Weber GFP 600</TD><TD class="col1">0.38</TD><TD class="col2">0.018(5%)</TD></TR></TBODY></TABLE></DIV><P>
Last measurement from experiment 32 (plate reader):
</P><DIV class="table sectionedit19"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> GFP </TH><TH class="col1"> concentration [mg/ml] </TH><TH class="col2"> error [mg/ml] </TH></TR><TR class="row1"><TD class="col0">Lysate HisGFP</TD><TD class="col1">0.62</TD><TD class="col2">0.17 (27%)</TD></TR><TR class="row2"><TD class="col0">Lysate noTag GFP</TD><TD class="col1">1.20</TD><TD class="col2">0.31 (26%)</TD></TR><TR class="row3"><TD class="col0">Weber GFP 6.8</TD><TD class="col1">7.76</TD><TD class="col2">2.04 (26%)</TD></TR><TR class="row4"><TD class="col0">Weber GFP 600</TD><TD class="col1">70.60</TD><TD class="col2">14.22 (20%)</TD></TR></TBODY></TABLE></DIV></DIV><H2 class="sectionedit20">Experiment 37a: PDITC iRIf slides for measurement with antigens</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> preparing 4 iRIf PDITC slides for measurement</DIV></LI><LI class="level1"><DIV class="li"> spot freshly purified antigens from ProtPur-group on 2 slides and measure with polyclonal antibodies for HIV and <A href="">HCV antigen</A> and with monoclonal antibodies for Tetanus and Salmonella (same antibodies that were used in Experiment 36a)</DIV></LI></UL></DIV><H3 class="sectionedit21">2015.07.29</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> prepared 4 iRIf slides with PDITC according to protocol</DIV></LI><LI class="level1"><DIV class="li"> plasma activation for 5 min at 80 L/h</DIV></LI><LI class="level1"><DIV class="li"> slides were incubated in APTES solutiion for 1 h 10 min instead of 30 min</DIV></LI><LI class="level1"><DIV class="li"> slides were incubated in PDITC solution for 2 h 30 min instead of 2 h</DIV></LI><LI class="level1"><DIV class="li"> 3 µL of antigens and controls (Max-GFP and bBSA) were spotted and incubated o/n at 4 °C</DIV></LI></UL><P>
spotting pattern:
</P><DIV class="table sectionedit22"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Elution no. </TH><TH class="col3"> Concentration </TH><TH class="col4"> Antibody </TH><TH class="col5"> AB-conc.[µg/ml] </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1"> HIV(17) </TD><TD class="col2"> 2 </TD><TD class="col3 rightalign">  1.0 mg/mL </TD><TD class="col4"> gp41 DDX1306 </TD><TD class="col5"> 20 </TD></TR><TR class="row2"><TD class="col0"> 3-4 </TD><TD class="col1"> HCV(10) </TD><TD class="col2"> 2 </TD><TD class="col3 rightalign">  0.74 mg/mL </TD><TD class="col5"> 20 </TD></TR><TR class="row3"><TD class="col0"> 5-6 </TD><TD class="col1"> Tetanus(11) </TD><TD class="col2"> 2 </TD><TD class="col3 rightalign">  3.75 mg/mL </TD><TD class="col4">HYB 278-01 </TD><TD class="col5"> 20 </TD></TR><TR class="row4"><TD class="col0"> 7-8 </TD><TD class="col1"> GFP </TD><TD class="col3 rightalign">  1.0 mg/mL </TD><TD class="col4"> a-GFP (goat;biotinylated)</TD><TD class="col5"> 5 </TD></TR><TR class="row5"><TD class="col0"> 9 </TD><TD class="col1"> bBSA </TD><TD class="col3 rightalign">  0.1 mg/mL </TD><TD class="col4">Strep-Cy5 </TD><TD class="col5"> (Strep-Cy5) 10 </TD></TR><TR class="row6"><TD class="col0"> 10-11 </TD><TD class="col1"> Salmonella(15) </TD><TD class="col2"> 2 </TD><TD class="col3 rightalign">  6.7 mg/mL </TD><TD class="col4"> a-Salmonella-(pIG15_1301)</TD><TD class="col5"> 100 </TD></TR><TR class="row7"><TD class="col4">anti-His (mouse)</TD><TD class="col5">20</TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit23">2015.07.30</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> After 23 h of incubation spots were blocked 2x 5 min with PDITC blocking solution</DIV></LI><LI class="level1"><DIV class="li"> blocked slides 45 min in 10 mg/mL BSA solution</DIV></LI><LI class="level1"><DIV class="li"> washed 2x in PBS</DIV></LI><LI class="level1"><DIV class="li"> slide 467 was washed 1x in deluted PBS</DIV></LI><LI class="level1"><DIV class="li"> slide 215 was washed 2x in deluted PBS</DIV></LI><LI class="level1"><DIV class="li"> slides were measured in iRIF </DIV></LI></UL></DIV><H4>Measurement</H4><DIV class="level4"><DIV class="table sectionedit24"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Step </TH><TH class="col1"> Solution </TH><TH class="col2"> Concentration </TH><TH class="col3"> Amount </TH></TR><TR class="row1"><TD class="col0">1</TD><TD class="col1">buffer</TD></TR><TR class="row2"><TD class="col0">2</TD><TD class="col1">BSA</TD><TD class="col2">10 mg/ml</TD><TD class="col3">330 µl</TD></TR><TR class="row3"><TD class="col0">3</TD><TD class="col1">buffer</TD></TR><TR class="row4"><TD class="col0">4</TD><TD class="col1">anti-GFP</TD><TD class="col2">5 mg/mL</TD><TD class="col3">300 µL</TD></TR><TR class="row5"><TD class="col0">5</TD><TD class="col1">buffer</TD></TR><TR class="row6"><TD class="col0">6</TD><TD class="col1">anti-HIV</TD><TD class="col2">20 µg/mL</TD><TD class="col3">300 µL</TD></TR><TR class="row7"><TD class="col0">7</TD><TD class="col1">buffer</TD></TR><TR class="row8"><TD class="col0">8</TD><TD class="col1">anti-HCV</TD><TD class="col2">20 µg/mL</TD><TD class="col3">300 µL</TD></TR><TR class="row9"><TD class="col0">9</TD><TD class="col1">buffer</TD></TR><TR class="row10"><TD class="col0">10</TD><TD class="col1">anti-Tetanus</TD><TD class="col2">20 µg/mL</TD><TD class="col3">300 µL</TD></TR><TR class="row11"><TD class="col0">11</TD><TD class="col1">buffer</TD></TR><TR class="row12"><TD class="col0">12</TD><TD class="col1">anti-Salmonella</TD><TD class="col2">1:2</TD><TD class="col3">300 µL</TD></TR><TR class="row13"><TD class="col0">13</TD><TD class="col1">buffer</TD></TR><TR class="row14"><TD class="col0">14</TD><TD class="col1">StrepCy5</TD><TD class="col2">5 µg/ml (in PBS:BSA = 1:1)</TD></TR></TBODY></TABLE></DIV></DIV><H4>Resuslts</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> Experiment was conducted in duplicate. Both measurements showed no antibody/antigen binding. Positive</DIV></LI></UL><P>
controls (GFP/anti-GFP, bBSA/Strep) performed well.
</P><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 215: Binding curves </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 215: ROI selection </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 467: Binding curves </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 467: ROI selection </DIV></DIV></DIV></DIV><H2 class="sectionedit25">Experiment 37b: PDITC iRIf slides for measurement with mouse and rabbit antibodies</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/SlidePrep" title="irif_slide_preparation">iRIf slide preparation</A></DIV></LI></UL></DIV><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> spot mouse and rabbit antibodies on remaining 2 slides from Experiment 37a and measure with anti-mouse/anti-rabbit</DIV></LI></UL></DIV><H3 class="sectionedit26">2015.07.29</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 3 µL of a antibody out of mouse, the HCV antibody (out of rabbit), GFP-antibody (out of goat - negative control) and positive controls (GFP, bBSA) were spotted on 2 PDITC iRIf slides and incubated o/n at 4 °C</DIV></LI></UL><P>
spotting pattern:
</P><DIV class="table sectionedit27"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Concentration </TH><TH class="col3"> Antibody </TH><TH class="col4"> AB-conc.[µg/ml] </TH></TR><TR class="row1"><TD class="col0"> 1-3 </TD><TD class="col1"> mouse AB </TD><TD class="col2 rightalign">  1 mg/mL </TD><TD class="col3 leftalign"> anti-mouse  </TD><TD class="col4"> 20 </TD></TR><TR class="row2"><TD class="col0"> 4-6 </TD><TD class="col1"> rabbit AB (anti-HCV) </TD><TD class="col2 rightalign">  1 mg/mL </TD><TD class="col3"> anti-rabbit </TD><TD class="col4"> 20 </TD></TR><TR class="row3"><TD class="col0"> 7-9 </TD><TD class="col1"> Max-GFP </TD><TD class="col2 rightalign">  1.0 mg/mL </TD><TD class="col3"> a-GFP (mouse;0.5 mg/ml) </TD><TD class="col4 rightalign">  5 </TD></TR><TR class="row4"><TD class="col0"> 10 </TD><TD class="col1"> Goat AB (anti-GFP) </TD><TD class="col2 rightalign">  0.2 mg/mL </TD><TD class="col3"> - </TD><TD class="col4"> - </TD></TR><TR class="row5"><TD class="col0"> 11 </TD><TD class="col1"> bBSA </TD><TD class="col2 rightalign">  0.1 mg/mL </TD><TD class="col3">Strep-Cy5 </TD><TD class="col4"> (Strep-Cy5) 10 </TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit28">2015.07.30</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> After 23 h of incubation spots were blocked 2x 5 min with PDITC blocking solution</DIV></LI><LI class="level1"><DIV class="li"> blocked slides 45 min in 10 mg/mL BSA solution</DIV></LI><LI class="level1"><DIV class="li"> washed 2x in PBS</DIV></LI><LI class="level1"><DIV class="li"> washed 1x in deluted PBS</DIV></LI><LI class="level1"><DIV class="li"> slides were measured in iRIF </DIV></LI><LI class="level1"><DIV class="li"> slide 1: 121 , slide 2: 287 </DIV></LI></UL></DIV><H4>Measurement</H4><DIV class="level4"><DIV class="table sectionedit29"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Step </TH><TH class="col1"> Solution </TH><TH class="col2"> Concentration </TH><TH class="col3"> Amount </TH></TR><TR class="row1"><TD class="col0">1</TD><TD class="col1">buffer</TD></TR><TR class="row2"><TD class="col0">2</TD><TD class="col1">BSA</TD><TD class="col2">10 mg/ml</TD><TD class="col3">470 µl</TD></TR><TR class="row3"><TD class="col0">3</TD><TD class="col1">buffer</TD></TR><TR class="row4"><TD class="col0">4</TD><TD class="col1">anti-Mouse</TD><TD class="col2">20 µg/ml (in PBS:BSA = 1:1)</TD><TD class="col3">330 µl</TD></TR><TR class="row5"><TD class="col0">5</TD><TD class="col1">buffer</TD></TR><TR class="row6"><TD class="col0">6</TD><TD class="col1">anti-Rabbit</TD><TD class="col2">20 µg/ml (in PBS:BSA = 1:1)</TD><TD class="col3">330 µl</TD></TR><TR class="row7"><TD class="col0">7</TD><TD class="col1">buffer</TD></TR><TR class="row8"><TD class="col0">8</TD><TD class="col1">anti-GFP</TD><TD class="col2">5 µg/ml (in PBS:BSA = 1:1)</TD><TD class="col3">330 µl</TD></TR><TR class="row9"><TD class="col0">9</TD><TD class="col1">buffer</TD></TR><TR class="row10"><TD class="col0">10</TD><TD class="col1">StrepCy5</TD><TD class="col2">5 µg/ml (in PBS:BSA = 1:1)</TD><TD class="col3">330 µl</TD></TR><TR class="row11"><TD class="col0">11</TD><TD class="col1">buffer</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> The secondary antibodies bound properly to their corresponding antibodies derived from mouse/rabbit.</DIV></LI></UL><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 121: binding curves </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 121: ROI selection </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: binding curves - different a-GFP was tested which did not bind to GFP </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: ROI selection </DIV></DIV></DIV></DIV><H2 class="sectionedit30">Experiment 36b: Ni-NTA slides for iRIf group - cell free expressed tYFP</H2><H3 class="sectionedit31">2015.07.27</H3><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> Spot cell free expressed YFP and mCherry-Lysate on remaining 2 iRIf slides from experiment 36a</DIV></LI></UL></DIV><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 3 µL of cell free expressed protein, mCherry and controls were spotted on the Ni-NTA slides from 2015.07.23. and incubated o/n</DIV></LI></UL><P>
spotting pattern:
</P><DIV class="table sectionedit32"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pIG15-104 Bernhard </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> pIG15-105 Bernhard </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> mCherry Lysate (HA-Tag)</TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> pIG15-104 Promega </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1"> pIG15-105 Promega </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1"> negative control with Promega </TD></TR><TR class="row7"><TD class="col0"> 10 </TD><TD class="col1"> pIG15-104 Retikulo </TD></TR><TR class="row8"><TD class="col0"> 11 </TD><TD class="col1"> pIG15-105 Retikulo </TD></TR><TR class="row9"><TD class="col0"> 7+8 </TD><TD class="col1"> Max-GFP 1mg/mL </TD></TR><TR class="row10"><TD class="col0"> 9 </TD><TD class="col1"> bBSA 100µg/mL </TD></TR></TBODY></TABLE></DIV><UL><LI class="level1"><DIV class="li"> protein spots incubated for 24 h at 4 °C</DIV></LI></UL></DIV><H3 class="sectionedit33">2015.07.28</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> Spots were blocked 2x 5 min with BSA 10 mg/ml at room temperature</DIV></LI><LI class="level1"><DIV class="li"> Slides were flushed with PBS 1x and spotting mask was removed</DIV></LI><LI class="level1"><DIV class="li"> Washing steps in slideholder at 4°C followed: 10 min PBS 1x, 10 min PBS + 20 mM Imidazol and 10 min 1/10 diluted PBS (in aqua dest)</DIV></LI><LI class="level1"><DIV class="li"> Then blocking for 30 min in BSA 10 mg/ml at 4°C followed</DIV></LI><LI class="level1"><DIV class="li"> Slides were washed for 10 min in PBS 1x and 10 min in 1/10 diluted PBS (in aqua dest) at 4°C</DIV></LI><LI class="level1"><DIV class="li"> After drying with wafer gun, fluorescence of YFP was checked in Microarray Scanner</DIV></LI><LI class="level1"><DIV class="li"> Slides were then measured in iRIf</DIV></LI></UL></DIV><H4>Measurement</H4><DIV class="level4"><P>
Slide 1
</P><DIV class="table sectionedit34"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Step </TH><TH class="col1"> Solution </TH><TH class="col2"> Concentration </TH><TH class="col3"> Amount </TH></TR><TR class="row1"><TD class="col0">1</TD><TD class="col1">buffer</TD></TR><TR class="row2"><TD class="col0">2</TD><TD class="col1">BSA</TD><TD class="col2">10 mg/ml</TD><TD class="col3">330 µl</TD></TR><TR class="row3"><TD class="col0">3</TD><TD class="col1">buffer</TD></TR><TR class="row4"><TD class="col0">4</TD><TD class="col1">anti tYFP</TD><TD class="col2">20 µg/ml (in PBS)</TD><TD class="col3">340 µl</TD></TR><TR class="row5"><TD class="col0">5</TD><TD class="col1">buffer</TD></TR><TR class="row6"><TD class="col0">6</TD><TD class="col1">anti-His</TD><TD class="col2">10 µg/ml (in PBS)</TD></TR><TR class="row7"><TD class="col0">7</TD><TD class="col1">buffer</TD></TR><TR class="row8"><TD class="col0">8</TD><TD class="col1">anti-GFP (goat, biotinylated)(in PBS:BSA = 1:1)</TD><TD class="col2">5 µg/ml</TD></TR><TR class="row9"><TD class="col0">9</TD><TD class="col1">buffer</TD></TR><TR class="row10"><TD class="col0">10</TD><TD class="col1">anti-HA</TD><TD class="col2">??? von Norman, 3 weeks old</TD></TR><TR class="row11"><TD class="col0">11</TD><TD class="col1">buffer</TD></TR><TR class="row12"><TD class="col0">12</TD><TD class="col1">StrepCy5</TD><TD class="col2">5 µg/ml (in PBS:BSA = 1:1)</TD></TR></TBODY></TABLE></DIV><P>

Slide 2
</P><DIV class="table sectionedit35"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Step </TH><TH class="col1"> Solution </TH><TH class="col2"> Concentration </TH><TH class="col3"> Amount </TH></TR><TR class="row1"><TD class="col0">1</TD><TD class="col1">buffer</TD></TR><TR class="row2"><TD class="col0">2</TD><TD class="col1">BSA</TD><TD class="col2">10 mg/ml</TD><TD class="col3">330 µl</TD></TR><TR class="row3"><TD class="col0">3</TD><TD class="col1">buffer</TD></TR><TR class="row4"><TD class="col0">4</TD><TD class="col1">anti tYFP</TD><TD class="col2">ca. 17 µg/ml (in PBS)</TD><TD class="col3">350 µl</TD></TR><TR class="row5"><TD class="col0">5</TD><TD class="col1">buffer</TD></TR><TR class="row6"><TD class="col0">6</TD><TD class="col1">anti-GFP (goat, biotinylated)(in PBS:BSA = 1:1)</TD><TD class="col2">5 µg/ml</TD><TD class="col3">340 µl</TD></TR><TR class="row7"><TD class="col0">7</TD><TD class="col1">buffer</TD></TR><TR class="row8"><TD class="col0">8</TD><TD class="col1">StrepCy5</TD><TD class="col2">5 µg/ml (in PBS:BSA = 1:1)</TD><TD class="col3">330 µl</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> there might be a very weak a-tYFP/tYFP binding </DIV></LI><LI class="level1"><DIV class="li"> concentration of expressed tYFP is too low for a convincing signal</DIV></LI></UL><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curve for S1: Only with lots of zooming anti-tYFP can be seen to bind tYFP (spot 4) within the binding curves (Exp. 36b)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Quotient picture (before/after anti-tYFP): Weak signal for Spot 4 can be seen</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curve for S2: Only with lots of zooming anti-tYFP can be seen to bind tYFP (spot 4) within the binding curves (Exp. 36b)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Quotient picture that was taken for spot marking</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:310px"><DIV class="thumbinner"><DIV class="thumbcaption">Quotient picture (before/after anti-tYFP): Weak signal for Spot 4 can be seen</DIV></DIV></DIV></DIV><H2 class="sectionedit36">Experiment 36a: Ni-NTA slides for iRIf group - antigens</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Ni_NTA" title="protocols:ni_nta">Ni-NTA</A></DIV></LI></UL></DIV><H3 class="sectionedit37">2015.07.22</H3><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> prepare Ni-NTA slides for the iRIf group to check the antibody binding to our expressed antigens</DIV></LI></UL></DIV><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> prepared 4 iRIf PDITC slides according to protocol</DIV></LI><LI class="level1"><DIV class="li"> plasma activation time: 5 min</DIV></LI><LI class="level1"><DIV class="li"> sandwiched them with NTA and incubated o/n at 4°C</DIV></LI></UL></DIV><H3 class="sectionedit38">2015.07.23</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> slides were blocked in APTES blocking solution for 1h in slideholder</DIV></LI><LI class="level1"><DIV class="li"> washed 2x 10 min with PBS (shaky, shaky)</DIV></LI><LI class="level1"><DIV class="li"> incubated slides in freshly prepared 1% NiSO<SUB>4</SUB> solution for 1h</DIV></LI><LI class="level1"><DIV class="li"> washed slides 2x 10 min in PBS and then 1x in 1/10 diluted PBS (shaky, shaky)</DIV></LI><LI class="level1"><DIV class="li"> spotted 3 µl antigen samples and controls (Max GFP, bBSA)and incubated them overnight</DIV></LI></UL><P>
spotting pattern:
</P><DIV class="table sectionedit39"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Elution no. </TH><TH class="col3"> Concentration </TH><TH class="col4"> Antibody </TH><TH class="col5"> AB-conc. </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1"> HIV(17) </TD><TD class="col2"> 2 </TD><TD class="col3"> 0.36 mg/ml </TD><TD class="col4"> gp41 DDX1306 </TD><TD class="col5"> 20 ug/ml </TD></TR><TR class="row2"><TD class="col0"> 3-4 </TD><TD class="col1"> HCV(10) </TD><TD class="col2"> Mix (1-3)</TD><TD class="col3"> 0.13 mg/ml </TD><TD class="col5"> 20 ug/ml </TD></TR><TR class="row3"><TD class="col0"> 5-6 </TD><TD class="col1"> Tetanus(11) </TD><TD class="col2"> Mix (1-3) </TD><TD class="col3"> 0.55 mg/ml </TD><TD class="col5"> 20 ug/ml </TD></TR><TR class="row4"><TD class="col0"> 7-8 </TD><TD class="col1"> GFP </TD><TD class="col3"> 1.0 mg/ml </TD><TD class="col4"> a-GFP (goat)</TD><TD class="col5"> 5 ug/ml </TD></TR><TR class="row5"><TD class="col0"> 9 </TD><TD class="col1"> bBSA </TD><TD class="col3"> 0.2 mg/ml </TD><TD class="col4">Strep-Cy5 </TD><TD class="col5"> 10 ug/ml </TD></TR><TR class="row6"><TD class="col0"> 10-11 </TD><TD class="col1"> Salmonella(15) </TD><TD class="col2"> 2 </TD><TD class="col3"> 3.2 mg/ml </TD><TD class="col4"> a-Salmonella-Lysate (13)</TD><TD class="col5"> 400 ug/ml (lysate conc.) </TD></TR></TBODY></TABLE></DIV><UL><LI class="level1"><DIV class="li"> 803 - (0.13 mg/ml) - not spotted</DIV></LI><LI class="level1"><DIV class="li"> Two slides were spotted. For first slide the (max.) concentrations of the Antigens were used. For the second slide the second spot of each Antigen was spotted diluted (100 ug/ml).</DIV></LI></UL></DIV><H3 class="sectionedit40">2015.07.24</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> After incubating for 13h at 4°C all spots were removed with pipette</DIV></LI><LI class="level1"><DIV class="li"> slides were then blocked with BSA (10 mg/ml) 2x 10 min at room temperature</DIV></LI><LI class="level1"><DIV class="li"> 1x PBS buffer was flooded over slides before removing the spotting mask and washing in PBS 2x 10 min (each time stored at 4°C) </DIV></LI><LI class="level1"><DIV class="li"> Then a washing step in 1/10 diluted PBS (with aqua dest.) followed (also at 4°C)</DIV></LI><LI class="level1"><DIV class="li"> Slides were dried with wafer gun and stored at 4°C in humid atmosphere</DIV></LI><LI class="level1"><DIV class="li"> After 15 min slides were put back in PBS for 10 min because of Stefan</DIV></LI><LI class="level1"><DIV class="li"> Talking to Günter confirmed that storing the slides dry prevents the His-Tag from leaving Ni/NTA so the slides were dipped into PBS (1/10 diluted, dried with wafer gun and stored at 4°C in humid atmosphere</DIV></LI><LI class="level1"><DIV class="li"> slides were blocked again in BSA 10 mg/ml for 30 min</DIV></LI><LI class="level1"><DIV class="li"> Then they were washed 10 min in PBS 1x and 10 min in 1/10 diluted PBS (in aqua dest), eacht time at 4°C</DIV></LI><LI class="level1"><DIV class="li"> Slides were dried and measured in iRIf</DIV></LI></UL></DIV><H4>Measurement</H4><DIV class="level4"><P>
Flush protocol for both slides
</P><DIV class="table sectionedit41"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">80</TD><TD class="col3">940</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">500</TD><TD class="col4">10 mg/mL</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">510</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-GFP(goat;biotinylated)</TD><TD class="col1">4</TD><TD class="col2">20</TD><TD class="col3">920</TD><TD class="col4">5 ug/mL</TD></TR><TR class="row5"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-HIV (polyclonal)</TD><TD class="col1">6</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/mL</TD></TR><TR class="row7"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-HCV (polyclonal)</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/mL</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Anti-Tetanus (mk: HYB 278-15)</TD><TD class="col1">10</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/mL</TD></TR><TR class="row11"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Strep-Cy5</TD><TD class="col1">12</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/mL</TD></TR><TR class="row13"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">Anti-His </TD><TD class="col1">14</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">20 µg/mL</TD></TR><TR class="row15"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row16"><TD class="col0">Anti-Salmonella (1301 Elu2)</TD><TD class="col1">16</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1.6 mg/mL 1:4</TD></TR><TR class="row17"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">17</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> No specific antigen/antibody binding</DIV></LI><LI class="level1"><DIV class="li"> positive control (GFP) worked</DIV></LI><LI class="level1"><DIV class="li"> negative control didn't work (bBSA was detectable with Strep-Cy5 although it should not bind to Ni-NTA)</DIV></LI><LI class="level1"><DIV class="li"> Anti-His at least bound to Tetanus and Samonella</DIV></LI><LI class="level1"><DIV class="li"> monoclonal antibodies did'nt bind </DIV></LI><LI class="level1"><DIV class="li"> for HIV, HCV: maybe concentration was too low</DIV></LI></UL><DIV class="thumb2 tleft" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curve of the second slide: No specific antibody/antigen binding can be seen</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curve of S1: results are equal to S2 (anti-Salm not present within this plot, since huge airbubble before the step destroyed further measurement)</DIV></DIV></DIV></DIV><H2 class="sectionedit42">Experiment 35: Influence of focus on fluorescence intensity</H2><H3 class="sectionedit43">2015.07.21</H3><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> check if there is an impact on the fluorescence intensity when the photo is taken out of focus (compared to in focus photo) </DIV></LI></UL></DIV><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> three photos of a spot were taken and evaluated, one of them in focus, the others out of focus</DIV></LI></UL></DIV><H4>Results</H4><DIV class="level4"><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Compared fluorescence intensities of images from the same spot taken with different focus calibrations </DIV></DIV></DIV><UL><LI class="level1"><DIV class="li"> there is no dependency between the fluorescence intensity and the focusing</DIV></LI></UL></DIV><H2 class="sectionedit44">Experiment 34: Influence of objcetive on fluorescence intensity</H2><H3 class="sectionedit45">2015.07.21</H3><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> check if fluorescence images made with the 10x objective are brighter than with the 4x objective</DIV></LI><LI class="level1"><DIV class="li"> how much brighter</DIV></LI></UL></DIV><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> made image of the same spot with 10x objective as well as the 4x objective</DIV></LI><LI class="level1"><DIV class="li"> measured 3 spots and compared fluorescence intensities</DIV></LI></UL></DIV><H4>Results</H4><DIV class="level4"><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Compared fluorescence intensities of images from the same spot taken with the 10x objective and the 4x objective</DIV></DIV></DIV><UL><LI class="level1"><DIV class="li"> as expected the images taken with the 10xobjective are brigther</DIV></LI><LI class="level1"><DIV class="li"> 3-10 time as bright as the 4x objective images</DIV></LI><LI class="level1"><DIV class="li"> comparison of images taken with the 4x and 10x objectives is difficult → use only one objective for spot evaluation    </DIV></LI></UL></DIV><H2 class="sectionedit46">Experiment 33: Photobleaching of GFP</H2><H3 class="sectionedit47">2015.07.21</H3><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> determine impact of photobleaching on the fluorescence measurement of GFP</DIV></LI></UL></DIV><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> took a photo every minute of 3 individual spots for 10 min while constantly illuminating them with blue light</DIV></LI><LI class="level1"><DIV class="li"> slides from experiment 30 were used</DIV></LI></UL></DIV><H4>Results</H4><DIV class="level4"><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Impact of photobleaching of GFP spots on measured fluorescence intensities.</DIV></DIV></DIV><P>
→ photobleaching effect negligible for the duration of our experiments
</P></DIV><H2 class="sectionedit48">Experiment 32: Dilution series of GFP III and fluorescence measurement</H2><H3 class="sectionedit49">2015.07.20</H3><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> repeat dilution series with different range of dilutions since no linearity could be observed in the previous experiment 29 </DIV></LI></UL></DIV><H4>Experiment/Protocol</H4><DIV class="level4"><P>
Scheme for dilutions in plate reader:
</P><DIV class="table sectionedit50"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col1"> 1 </TH><TH class="col2"> 2 </TH><TH class="col3"> 3 </TH><TH class="col4"> 4 </TH><TH class="col5"> 5 </TH><TH class="col6"> 6 </TH><TH class="col7"> 7 </TH><TH class="col8"> 8 </TH><TH class="col9"> 9 </TH><TH class="col10"> 10 </TH><TH class="col11"> 11 </TH><TH class="col12"> 12 </TH></TR><TR class="row1"><TD class="col0"><STRONG>A</STRONG></TD><TD class="col1">PBS</TD><TD class="col2">PBS</TD><TD class="col3">PBS</TD></TR><TR class="row2"><TD class="col0"><STRONG>B</STRONG> Max GFP</TD><TD class="col1">pure</TD><TD class="col2">1:2</TD><TD class="col3">1:4</TD><TD class="col4">1:8</TD><TD class="col5">1:10</TD><TD class="col6">1:15</TD><TD class="col7">1:20</TD><TD class="col8">1:30</TD></TR><TR class="row3"><TD class="col0"><STRONG>C</STRONG> Max GFP</TD><TD class="col1">pure</TD><TD class="col2">1:2</TD><TD class="col3">1:4</TD><TD class="col4">1:8</TD><TD class="col5">1:10</TD><TD class="col6">1:15</TD><TD class="col7">1:20</TD><TD class="col8">1:30</TD></TR><TR class="row4"><TD class="col0"><STRONG>D</STRONG> Max GFP</TD><TD class="col1">pure</TD><TD class="col2">1:2</TD><TD class="col3">1:4</TD><TD class="col4">1:8</TD><TD class="col5">1:10</TD><TD class="col6">1:15</TD><TD class="col7">1:20</TD><TD class="col8">1:30</TD></TR><TR class="row5"><TD class="col0"><STRONG>E</STRONG> Lysate His-GFP</TD><TD class="col1">1:2</TD><TD class="col2">1:2</TD><TD class="col3">1:5</TD><TD class="col4">1:5</TD><TD class="col5">1:10</TD><TD class="col6">1:10</TD><TD class="col7">1:20</TD><TD class="col8">1:20</TD><TD class="col9">1:40</TD><TD class="col10">1:40</TD></TR><TR class="row6"><TD class="col0"><STRONG>F</STRONG> Lysate GFP no Tag</TD><TD class="col1">1:2</TD><TD class="col2">1:2</TD><TD class="col3">1:5</TD><TD class="col4">1:5</TD><TD class="col5">1:10</TD><TD class="col6">1:10</TD><TD class="col7">1:20</TD><TD class="col8">1:20</TD><TD class="col9">1:40</TD><TD class="col10">1:40</TD></TR><TR class="row7"><TD class="col0"><STRONG>G</STRONG> Weber GFP 8.6 mg/ml</TD><TD class="col1">1:20</TD><TD class="col2">1:20</TD><TD class="col3">1:50</TD><TD class="col4">1:50</TD><TD class="col5">1:100</TD><TD class="col6">1:100</TD><TD class="col7">1:200</TD><TD class="col8">1:200</TD><TD class="col9">1:500</TD><TD class="col10">1:500</TD></TR><TR class="row8"><TD class="col0"><STRONG>H</STRONG> Weber GFP 600 mg/ml</TD><TD class="col1">1:200</TD><TD class="col2">1:200</TD><TD class="col3">1:500</TD><TD class="col4">1:500</TD><TD class="col5">1:1000</TD><TD class="col6">1:1000</TD><TD class="col7">1:2000</TD><TD class="col8">1:2000</TD><TD class="col9">1:4000</TD><TD class="col10">1:4000</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><P>
First Measurement 

Second Measurement with shaking (30s) </P></DIV><H3 class="sectionedit51">2015.07.21</H3><H4>Evaluation</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> Measured fluorescence values were corrected by mean intensity for PBS</DIV></LI><LI class="level1"><DIV class="li"> for each dilution the mean value of the corrected intensities was calculated</DIV></LI><LI class="level1"><DIV class="li"> A calibration curve was made from the values for Max GFP (c = 1mg/ml)</DIV></LI></UL><UL><LI class="level1"><DIV class="li"> The concentrations of the other GFP solutions were calculated by using the equation obtained from the calibration and multiplying with the dilution factor.</DIV></LI><LI class="level1"><DIV class="li"> The final concentration was obtained by calculating the mean value for all 5 dilutions. The error corresponds to the standard deviation of these 5 values.</DIV></LI></UL><DIV class="table sectionedit52"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> GFP </TH><TH class="col1"> concentration [mg/ml] </TH><TH class="col2"> error [mg/ml] </TH></TR><TR class="row1"><TD class="col0">Lysate HisGFP</TD><TD class="col1">0.62</TD><TD class="col2">0.17 (27%)</TD></TR><TR class="row2"><TD class="col0">Lysate noTag GFP</TD><TD class="col1">1.20</TD><TD class="col2">0.31 (26%)</TD></TR><TR class="row3"><TD class="col0">Weber GFP 6.8</TD><TD class="col1">7.76</TD><TD class="col2">2.04 (26%)</TD></TR><TR class="row4"><TD class="col0">Weber GFP 600</TD><TD class="col1">70.60</TD><TD class="col2">14.22 (20%)</TD></TR></TBODY></TABLE></DIV></DIV><H2 class="sectionedit53">Experiment 31: Ni/NTA slides for iRIf</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/GOPTS_Surface" title="protocols:gopts_surface">GOPTS surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Ni_NTA" title="protocols:ni_nta">Ni-NTA</A></DIV></LI></UL></DIV><H3 class="sectionedit54">2015.07.19</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 2 iRIf slides were made until after loading the NTA surface with Ni</DIV></LI><LI class="level1"><DIV class="li"> slides were plasma activated for 5 min at gas flow 80 L/h</DIV></LI><LI class="level1"><DIV class="li"> Spotting pattern:</DIV></LI></UL><DIV class="table sectionedit55"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH></TR><TR class="row1"><TD class="col0"> 1-3 </TD><TD class="col1"> APTES+PDITC+NTA+Ni+Lysate His-GFP </TD></TR><TR class="row2"><TD class="col0"> 4-6 </TD><TD class="col1"> APTES+PDITC+Lysate His-GFP </TD></TR><TR class="row3"><TD class="col0"> 7-9 </TD><TD class="col1"> APTES+PDITC+NTA+Ni+Max GFP </TD></TR><TR class="row4"><TD class="col0"> 10 </TD><TD class="col1"> APTES+PDITC+NTA+bBSA </TD></TR><TR class="row5"><TD class="col0"> 11 </TD><TD class="col1"> APTES+PDITC+bBSA </TD></TR></TBODY></TABLE></DIV><UL><LI class="level1"><DIV class="li"> slides were incubated in PDITC solution for 3h15min</DIV></LI><LI class="level1"><DIV class="li"> NTA solution from 04.07.2015 was used</DIV></LI><LI class="level1"><DIV class="li"> spotted slides were incubated overnight in the fridge at 4°C and humid atmosphere</DIV></LI></UL></DIV><H3 class="sectionedit56">2015.07.20</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> slides were blocked by spotting APTES blocking solution on all spots (also PDITC-spots).</DIV></LI><LI class="level1"><DIV class="li"> slides were washed 2x in PBS in petri dish</DIV></LI><LI class="level1"><DIV class="li"> NiSO<SUB>4</SUB> was spotted on the NTA-spots and incubated for 1h15min</DIV></LI><LI class="level1"><DIV class="li"> Slides were washed 2x with PBS + 1x with diluted PBS in glass vase</DIV></LI><LI class="level1"><DIV class="li"> GFPs were spotted according to spotting pattern and incubated o/n at 4°C</DIV></LI></UL></DIV><H3 class="sectionedit57">2015.07.21</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> GFP was removed from slide and spots were incubated 2x with BSA (10 mg/mL)for 5 min</DIV></LI><LI class="level1"><DIV class="li"> slides were floated with PBS, then washed 2x with PBS in slide holder for 10 min</DIV></LI><LI class="level1"><DIV class="li"> slides were washed with deluted PBS (1:10) + Imidazole (20 mM)</DIV></LI><LI class="level1"><DIV class="li"> slide 1 was again washed in deluted PBS (1:10) and then measured in iRIf</DIV></LI><LI class="level1"><DIV class="li"> slide 2 was stored in deluted PBS (1:10)</DIV></LI></UL></DIV><H4>Measurement</H4><DIV class="level4"><DIV class="table sectionedit58"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Step </TH><TH class="col1"> Solution </TH><TH class="col2"> Concentration </TH><TH class="col3"> Amount </TH></TR><TR class="row1"><TD class="col0">1</TD><TD class="col1">buffer</TD></TR><TR class="row2"><TD class="col0">2</TD><TD class="col1">BSA</TD><TD class="col2">10 mg/ml</TD><TD class="col3">330 µl</TD></TR><TR class="row3"><TD class="col0">3</TD><TD class="col1">buffer</TD></TR><TR class="row4"><TD class="col0">4</TD><TD class="col1">anti-GFP (goat, biotinylated)(in PBS:BSA = 1:1)</TD><TD class="col2">5 µg/ml</TD><TD class="col3">340 µl</TD></TR><TR class="row5"><TD class="col0">5</TD><TD class="col1">buffer</TD></TR><TR class="row6"><TD class="col0">6</TD><TD class="col1">StrepCy5</TD><TD class="col2">5 µg/ml (in PBS:BSA = 1:1)</TD><TD class="col3">330 µl</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">slide 1</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:410px"><DIV class="thumbinner"><DIV class="thumbcaption">slide 2</DIV></DIV></DIV><UL><LI class="level1"><DIV class="li"> slide 1 was full of salt, therefore slide 2 was washed longer in deluted PBS</DIV></LI><LI class="level1"><DIV class="li"> for slide 2 the blocking step wasn't long enough, we should block more</DIV></LI></UL></DIV><H2 class="sectionedit59">Experiment 30: SaNSibar 2.0</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/GOPTS_Surface" title="protocols:gopts_surface">GOPTS surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Ni_NTA" title="protocols:ni_nta">Ni-NTA</A></DIV></LI></UL></DIV><H3 class="sectionedit60">2015.07.19</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> replicate experiment 27 from 30.6.2015</DIV></LI><LI class="level1"><DIV class="li"> Each slide was treated only by one person.</DIV></LI><LI class="level1"><DIV class="li"> Spotting pattern:</DIV></LI></UL><DIV class="table sectionedit61"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH></TR><TR class="row1"><TD class="col0">1-3</TD><TD class="col1"> HisGFP lysate </TD><TD class="col2"> on Ni/NTA </TD></TR><TR class="row2"><TD class="col0">4-6</TD><TD class="col1"> GFP no tag lysate </TD></TR><TR class="row3"><TD class="col0">7-9</TD><TD class="col1"> Max GFP </TD></TR><TR class="row4"><TD class="col0">10-12</TD><TD class="col1"> Weber GFP 600 mg/ml </TD></TR><TR class="row5"><TD class="col0">13-15</TD><TD class="col1 rightalign">  HisGFP lysate </TD><TD class="col2"> only on APTES/PDITC, no NTA</TD></TR><TR class="row6"><TD class="col0">16-18</TD><TD class="col1 rightalign">  GFP no tag lysate </TD></TR><TR class="row7"><TD class="col0">19-21</TD><TD class="col1 rightalign">  Max GFP </TD></TR><TR class="row8"><TD class="col0">22-24</TD><TD class="col1 rightalign">  Weber GFP 600 mg/ml </TD></TR><TR class="row9"><TD class="col0">25</TD><TD class="col1"> bBSA </TD><TD class="col2"> on Ni/NTA </TD></TR><TR class="row10"><TD class="col0">26</TD><TD class="col1"> bBSA </TD><TD class="col2"> only on APTES/PDITC, no NTA</TD></TR></TBODY></TABLE></DIV><UL><LI class="level1"><DIV class="li"> slides were incubated in PDITC solution for 3h15min</DIV></LI><LI class="level1"><DIV class="li"> NTA solution from 04.07.2015 was used</DIV></LI><LI class="level1"><DIV class="li"> spotted slides were incubated overnight in the fridge at 4°C and humid atmosphere</DIV></LI></UL></DIV><H3 class="sectionedit62">2015.07.20</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> slides were blocked by spotting APTES blocking solution on the NTA-spots for 1 hour</DIV></LI><LI class="level1"><DIV class="li"> on <STRONG>Sa</STRONG>-slide the blocking solution was also spotted on the PDITC-spots</DIV></LI><LI class="level1"><DIV class="li"> slides were washed 2x in PBS in petri dish</DIV></LI><LI class="level1"><DIV class="li"> NiSO4 was spotted on the NTA-spots and incubated for 1h15min</DIV></LI><LI class="level1"><DIV class="li"> Slides were washed 2x with PBS + 1x with diluted PBS in glass vase</DIV></LI><LI class="level1"><DIV class="li"> GFPs were spotted according to spotting pattern and incubated o/n at 4°C</DIV></LI><LI class="level1"><DIV class="li"> on <STRONG>Sa</STRONG>-slide there is 1 additional His-GFP-Lysate spot below spot nr. 15</DIV></LI></UL></DIV><H3 class="sectionedit63">2015.07.21</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> GFP was removed from slide and spots were incubated 2x with BSA (10 mg/mL)for 5 min</DIV></LI><LI class="level1"><DIV class="li"> slides were floated with PBS, then washed 2x with PBS in slide holder for 10 min</DIV></LI><LI class="level1"><DIV class="li"> slides were washed with deluted PBS (1:10) + Imidazole (20 mM)</DIV></LI><LI class="level1"><DIV class="li"> GFP fluorescence was measured</DIV></LI><LI class="level1"><DIV class="li"> slides were incubated with Strep-Cy5 for 45 min and washed according to protocol</DIV></LI><LI class="level1"><DIV class="li"> Cy5 fluorescence was measured</DIV></LI></UL></DIV><H3 class="sectionedit64">2015.07.21</H3><H4>Results</H4><DIV class="level4"><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Mean GFP Fluorescence Intensity of all slides + Mean Background for each slide.</DIV></DIV></DIV><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Mean Cy5 Fluorescence Intensity of all slides + Mean Background for each slide</DIV></DIV></DIV><UL><LI class="level1"><DIV class="li"> on Si slide the second bBSA spot (on PDITC) is missing (wasn't spotted)</DIV></LI></UL></DIV><H2 class="sectionedit65">Experiment 29: Measured fluorescence of dilution series of GFP to determine concentration</H2><H3 class="sectionedit66">2015.07.18</H3><DIV class="level3"><P>
Scheme for dilutions in plate reader:
</P><DIV class="table sectionedit67"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col1"> 1 </TH><TH class="col2"> 2 </TH><TH class="col3"> 3 </TH><TH class="col4"> 4 </TH><TH class="col5"> 5 </TH><TH class="col6"> 6 </TH><TH class="col7"> 7 </TH><TH class="col8"> 8 </TH><TH class="col9"> 9 </TH><TH class="col10"> 10 </TH><TH class="col11"> 11 </TH></TR><TR class="row1"><TD class="col0">A</TD><TD class="col1">H<SUB>2</SUB>O</TD><TD class="col2">Max GFP 1:10</TD><TD class="col3">Max GFP 1:20</TD><TD class="col4">Max GFP 1:30</TD><TD class="col5">Max GFP 1:40</TD><TD class="col6">Max GFP 1:50</TD><TD class="col7">Max GFP 1:60</TD><TD class="col8">Max GFP 1:70</TD><TD class="col9">Max GFP 1:80</TD><TD class="col10">Max GFP 1:90</TD><TD class="col11">Max GFP 1:100</TD></TR><TR class="row2"><TD class="col0">B</TD><TD class="col1">PBS</TD><TD class="col2">Lysate His-GFP 1:10</TD><TD class="col3">Lysate His-GFP 1:20</TD><TD class="col4">Lysate His-GFP 1:40</TD><TD class="col5">Lysate His-GFP 1:80</TD><TD class="col6">Lysate His-GFP 1:100</TD></TR><TR class="row3"><TD class="col0">C</TD><TD class="col2">Lysate GFP no Tag 1:10</TD><TD class="col3">Lysate GFP no Tag 1:20</TD><TD class="col4">Lysate GFP no Tag 1:40</TD><TD class="col5">Lysate GFP no Tag 1:80</TD><TD class="col6">Lysate GFP no Tag 1:100</TD></TR><TR class="row4"><TD class="col0">D</TD><TD class="col2">Weber GFP 8.6 mg/ml 1:50</TD><TD class="col3">Weber GFP 8.6 mg/ml 1:100</TD><TD class="col4">Weber GFP 8.6 mg/ml 1:200</TD><TD class="col5">Weber GFP 8.6 mg/ml 1:500</TD><TD class="col6">Weber GFP 8.6 mg/ml 1:1000</TD></TR><TR class="row5"><TD class="col0">E</TD><TD class="col2">Weber GFP 600 mg/ml 1:100</TD><TD class="col3">Weber GFP 600 mg/ml 1:500</TD><TD class="col4">Weber GFP 600 mg/ml 1:700</TD><TD class="col5">Weber GFP 600 mg/ml 1:1000</TD><TD class="col6">Weber GFP 600 mg/ml 1:2000</TD></TR></TBODY></TABLE></DIV></DIV><H4>Results</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> No linear correlation was obtained for the Max GFP dilutions.</DIV></LI><LI class="level1"><DIV class="li"> The fluorescence intensity of the majority of the chosen Max GFP dilutions was very low.</DIV></LI><LI class="level1"><DIV class="li"> –&gt; Experiment should be repeated with different dilutions (less diluted) and triplicates in order to obtain a calibration curve.</DIV></LI></UL></DIV><H2 class="sectionedit68">Experiment 28: Comparison of different GFPs on old Ni/NTA surfaces from 2015.06.15</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/GOPTS_Surface" title="protocols:gopts_surface">GOPTS surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Ni_NTA" title="protocols:ni_nta">Ni-NTA</A></DIV></LI></UL></DIV><H3 class="sectionedit69">2015.07.06</H3><DIV class="level3"><UL><LI class="level1"><DIV class="li"> 2 GOPTS and 2 APTES/PDITC slides, each modified with Ni/NTA from 15.06.2015, Experiment 18 (Had been stored in the fridge at 4°C since then)</DIV></LI><LI class="level1"><DIV class="li"> For spotting 11-well spotting mask was used. Each well was filled with 3 µl solution.</DIV></LI><LI class="level1"><DIV class="li"> Spotting pattern: </DIV></LI></UL><DIV class="table sectionedit70"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH></TR><TR class="row1"><TD class="col0"> 1-3 </TD><TD class="col1"> HisGFP lysate </TD></TR><TR class="row2"><TD class="col0"> 4-6 </TD><TD class="col1"> GFP lysate no Tag</TD></TR><TR class="row3"><TD class="col0"> 7-9 </TD><TD class="col1"> Weber GFP 8.6 mg/mL / For 2 slides 600 mg/mL (marked with black points in upper left-hand corner) </TD></TR><TR class="row4"><TD class="col0"> 10 </TD><TD class="col1"> bBSA </TD></TR><TR class="row5"><TD class="col0"> 11 </TD><TD class="col1"> bBSA </TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit71">2015.07.07.</H3><DIV class="level3"><UL><LI class="level1"><DIV class="li"> protein solutions were removed with pipette</DIV></LI><LI class="level1"><DIV class="li"> spots were blocked with 10 mg/ml BSA solution for 5 min</DIV></LI><LI class="level1"><DIV class="li"> spotting masks were removed</DIV></LI><LI class="level1"><DIV class="li"> slides were washed 2×10 min in PBS buffer </DIV></LI></UL></DIV><H4>Results</H4><DIV class="level4"><DIV class="thumb2 trien" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Mean Fluorescence Intensity of different GFPs on old NTA slides_all slides each spot.</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Mean Fluorescence Intensity of different GFPs on old NTA slides_only PDITC slides Mean of 3 spots per GFP.</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Mean Fluorescence Intensity of bBSA-Strep-Cy5 on old NTA slides.</DIV></DIV></DIV></DIV><H2 class="sectionedit72">Experiment 27: Comparison of different GFPs on Ni/NTA APTES/PDITC surface, replicate 1 (SaNSibar)</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Ni_NTA" title="protocols:ni_nta">Ni-NTA</A></DIV></LI></UL></DIV><H3 class="sectionedit73">2015.07.06</H3><DIV class="level3"><UL><LI class="level1"><DIV class="li"> 3 slides were prepared according to the protocols.</DIV></LI><LI class="level1"><DIV class="li"> Each slide was treated only by one person.</DIV></LI><LI class="level1"><DIV class="li"> Spotting pattern:</DIV></LI></UL><DIV class="table sectionedit74"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH></TR><TR class="row1"><TD class="col0">1-3</TD><TD class="col1"> HisGFP lysate </TD><TD class="col2"> on Ni/NTA </TD></TR><TR class="row2"><TD class="col0">4-6</TD><TD class="col1"> GFP no tag lysate </TD></TR><TR class="row3"><TD class="col0">7-9</TD><TD class="col1"> Max GFP </TD></TR><TR class="row4"><TD class="col0">10-12</TD><TD class="col1"> Weber GFP 8.6 mg/ml </TD></TR><TR class="row5"><TD class="col0">13-15</TD><TD class="col1 rightalign">  HisGFP lysate </TD><TD class="col2"> only on APTES/PDITC, no NTA</TD></TR><TR class="row6"><TD class="col0">16-18</TD><TD class="col1 rightalign">  GFP no tag lysate </TD></TR><TR class="row7"><TD class="col0">19-21</TD><TD class="col1 rightalign">  Max GFP </TD></TR><TR class="row8"><TD class="col0">22-24</TD><TD class="col1 rightalign">  Weber GFP 8.6 mg/ml </TD></TR><TR class="row9"><TD class="col0">25</TD><TD class="col1"> bBSA </TD><TD class="col2"> on Ni/NTA </TD></TR><TR class="row10"><TD class="col0">26</TD><TD class="col1"> bBSA </TD><TD class="col2"> only on APTES/PDITC, no NTA</TD></TR></TBODY></TABLE></DIV><UL><LI class="level1"><DIV class="li"> spotted slides were incubated overnight in the fridge at 4°C and humid atmosphere</DIV></LI></UL></DIV><H3 class="sectionedit75">2015.07.07</H3><DIV class="level3"><UL><LI class="level1"><DIV class="li"> protein solutions were removed with pipette</DIV></LI><LI class="level1"><DIV class="li"> slides were blocked with BSA 5 mg/ml + 5% ethanolamine in PBS for 45 min</DIV></LI><LI class="level1"><DIV class="li"> slides were washed 2×10 min in PBS buffer without removing spotting mask</DIV></LI></UL></DIV><H4>Results</H4><DIV class="level4"><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Mean GFP Fluorescence Intensity out of three spots + mean background over whole slides.</DIV></DIV></DIV><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Mean Cy5 Fluorescence Intensity + mean background.</DIV></DIV></DIV><P>
–&gt; His-GFP-Lysate binds best on Ni-NTA, Weber GFP binds best on PDITC.
</P></DIV><H2 class="sectionedit76">Experiment 26: Spotted NTA on PDITC slides to determine amount of unspecific binding</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/GOPTS_Surface" title="protocols:gopts_surface">GOPTS surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Ni_NTA" title="protocols:ni_nta">Ni-NTA</A></DIV></LI></UL></DIV><H3 class="sectionedit77">2015.07.02</H3><H4>considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> determine unspecific binding on Ni-NTA surface</DIV></LI></UL></DIV><H4>Experiment/Protocols</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> prepared 3 APTES/PDITC slides according to <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A></DIV></LI><LI class="level1"><DIV class="li"> spotted 2 µl NTA (457 mM in 1 M NaHCO<SUB>3</SUB>)using the spotting templates</DIV></LI><LI class="level1"><DIV class="li"> spotting pattern:</DIV></LI></UL><DIV class="table sectionedit78"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH></TR><TR class="row1"><TD class="col0"> 1-3 </TD><TD class="col1"> PDITC + NTA + Blocking + His-GFP lysate </TD></TR><TR class="row2"><TD class="col0"> 4-6 </TD><TD class="col1"> PDITC + NTA + Blocking + Weber His-GFP 8 mg/mL </TD></TR><TR class="row3"><TD class="col0"> 7-8 </TD><TD class="col1"> PDITC + NTA + Blocking + nT-GFP lysate </TD></TR><TR class="row4"><TD class="col0"> 9 </TD><TD class="col1"> PDITC + BSA </TD></TR><TR class="row5"><TD class="col0"> 10 </TD><TD class="col1"> PDITC + Spotting control (cy5 labeled DNA) </TD></TR><TR class="row6"><TD class="col0"> 11 </TD><TD class="col1"> PDITC + positive control (nT-GFP lysate) </TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit79">2015.07.03</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> slides were washed with PBS according to <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Ni_NTA" title="protocols:ni_nta">Ni-NTA</A><STRONG>with spotting mask still on slide</STRONG></DIV></LI><LI class="level1"><DIV class="li"> 1 % Nickelsulfate solution was spotted on top of the NTA spots (Spot 1-8)</DIV></LI><LI class="level1"><DIV class="li"> slides were again washed with PBS according to <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Ni_NTA" title="protocols:ni_nta">Ni-NTA</A><STRONG>with spotting mask still on slide</STRONG></DIV></LI><LI class="level1"><DIV class="li"> GFP, His-GFP, BSA and Cy5-labeled DNA were spotted as mentioned in the table above (Experiment 25, 2.7.2015)</DIV></LI></UL></DIV><H3 class="sectionedit80">2015.07.04</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> removed protein and DNA solution with pipette</DIV></LI><LI class="level1"><DIV class="li"> incubated twice with 4 µl of BSA (10mg/ml) for 5 min</DIV></LI><LI class="level1"><DIV class="li"> washed twice with PBS for 10 min</DIV></LI><LI class="level1"><DIV class="li"> washed with 10% PBS with 20mM imidazole (27,2 mg in 20 ml PBS) for 10 min</DIV></LI><LI class="level1"><DIV class="li"> washed with 10% PBS for 10 min</DIV></LI><LI class="level1"><DIV class="li"> dried slides with nitrogengun and measured GFP fluorescence</DIV></LI></UL></DIV><H4>Results</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> in the diagrams the results for slide 2 and 3 are shown. On slide 1 not all spots were visible.</DIV></LI></UL><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Mean Fluorescence Intensities of slides 2 and 3 with measured background for each spot.</DIV></DIV></DIV><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Mean Fluorescence Intensities of slides 2 and 3 with background already substracted.</DIV></DIV></DIV><UL><LI class="level1"><DIV class="li"> The diagramm shows, that His-GFP was successfully immobilized on the Ni-NTA surface, while GFP without Tag didn't bind very good</DIV></LI><LI class="level1"><DIV class="li"> the fluorescence of our lysate was much stronger than that of the purified His-GFP</DIV></LI><LI class="level1"><DIV class="li"> the positive control (nT-GFP on PDITC) didn't show intense fluorescence, because nT-GFP-Lysate was used</DIV></LI></UL></DIV><H3 class="sectionedit81">To-Do</H3><DIV class="level3"><UL><LI class="level1"><DIV class="li"> Repeat dilution series (2 slides, 5 concentrations: 2 spots each, 1:1, 1:4, 1:16, 1:64, 1:256)</DIV></LI><LI class="level1"><DIV class="li"> shutterspeed linearity –&gt; ask Max</DIV></LI><LI class="level1"><DIV class="li"> re-evaluate shutterspeed linearity with NEF-Data from the old dataset (26.05.15)</DIV></LI><LI class="level1"><DIV class="li"> Talk to Günther </DIV></LI><LI class="level2"><DIV class="li"> about what to do next</DIV></LI><LI class="level2"><DIV class="li"> reference values for their Cy5 (How good are our slides?)</DIV></LI><LI class="level2"><DIV class="li"> GFP - why no homogenous spots but rings</DIV></LI><LI class="level2"><DIV class="li"> test if His binds to Ni or to PDITC/NTA by making NTA-spots without Ni</DIV></LI></UL><DIV class="noteimportant">Store slides for GFP incubation in fridge in plastic dishes with top of the dish beneath the slide (dish upside down)
</DIV><DIV class="notetip">spin GFP before use to separate conglomerates from solution
</DIV></DIV><H2 class="sectionedit82">Experiment 25: Check detectibility of GFP bound on PDITC slides in the iRIf setup</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/GOPTS_Surface" title="protocols:gopts_surface">GOPTS surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A></DIV></LI></UL></DIV><H3 class="sectionedit83">2015.07.01</H3><H4>Considerations</H4><DIV class="level4"><OL><LI class="level1"><DIV class="li"> repeat experiment from 2015.06.30 (different GFPs, mCherry, bBSA, bDNA, Cy5DNA on PDITC) on 2 iRIf slides</DIV></LI></OL><DIV class="noteclassic">New 2 ml Eppi of fresh APTES from abcr was prepared and used
</DIV></DIV><H4>Experiment/Protocols</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> 3 iRIf slides</DIV></LI><LI class="level1"><DIV class="li"> surface was prepared according to <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A> and <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A></DIV></LI><LI class="level1"><DIV class="li"> incubation in PDITC solution was 5h instead of 2h</DIV></LI><LI class="level1"><DIV class="li"> slides were spotted (2 µl spots) according to the following pattern:</DIV></LI></UL><DIV class="table sectionedit84"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> Lysate GFP no tag </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> Lysate GFP-2x6His </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> Max' GFP-His </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> Weber GFP 8.6 mg/mL </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1"> Weber GFP 600 mg/mL </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1"> mCherry </TD></TR><TR class="row7"><TD class="col0"> 7 </TD><TD class="col1"> BSA 10 mg/mL </TD></TR><TR class="row8"><TD class="col0">8+9 </TD><TD class="col1"> bBSA 50 ng/µL </TD></TR><TR class="row9"><TD class="col0"> 10 </TD><TD class="col1"> spotting control 2 µL </TD></TR><TR class="row10"><TD class="col0"> 11 </TD><TD class="col1"> binding control 0.5 µL </TD></TR></TBODY></TABLE></DIV><DIV class="noteclassic">Missing corner of spotting mask was in the upper left hand corner of the slide (slide 1: number on left side, 
</DIV></DIV><H4>Results</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> due to defects of the iRIf setup no measurement was taken</DIV></LI><LI class="level1"><DIV class="li"> the iRIf-slides were cleaned for reuse</DIV></LI></UL></DIV><H2 class="sectionedit85">Experiment 24: Compare quality of own PDITC surface with that of AG Roth</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/GOPTS_Surface" title="protocols:gopts_surface">GOPTS surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A></DIV></LI></UL></DIV><H3 class="sectionedit86">2015.07.01</H3><H4>Considerations</H4><DIV class="level4"><OL><LI class="level1"><DIV class="li"> compare our slides with slides from Norman</DIV></LI></OL><DIV class="noteclassic">New 2 ml Eppi of fresh APTES from abcr was prepared and used
</DIV></DIV><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> one of Norman's slides prepared by Norman and one of our slides prepared by us</DIV></LI><LI class="level1"><DIV class="li"> 2 of the prepared iRIf-PDITC-slides were spotted according to the following pattern/table</DIV></LI><LI class="level1"><DIV class="li"> GFP was taken away from well with pipette and immediately replaced by 10 µl of BSA (10 mg/ml)</DIV></LI><LI class="level1"><DIV class="li"> this step was carried out 2x</DIV></LI><LI class="level1"><DIV class="li"> slides were then washed with PBS from squeeze bottle, the spotting mask was removed and the slides were immediately put into a slideholder filled with PBS/BSA for 15 min</DIV></LI><LI class="level1"><DIV class="li"> GFP stock concentrations with 0.5 mg/mL</DIV></LI><LI class="level1"><DIV class="li"> on our slide the BSA spot is left to the bBSA spot</DIV></LI><LI class="level1"><DIV class="li"> on Normans slide the BSA spot is right to the bBSA Spot</DIV></LI></UL><DIV class="table sectionedit87"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> GFP Norman 1:10 </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> GFP Norman 1:30 </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> GFP Norman 1:100 </TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> GFP Max 1:10 </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1"> GFP Max 1:30 </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1"> GFP Max 1:100 </TD></TR><TR class="row7"><TD class="col0"> 7 </TD><TD class="col1"> GFP Weber 1:10 </TD></TR><TR class="row8"><TD class="col0"> 8 </TD><TD class="col1"> GFP Weber 1:30 </TD></TR><TR class="row9"><TD class="col0"> 9 </TD><TD class="col1"> GFP Weber 1:100 </TD></TR><TR class="row10"><TD class="col0"> 10 </TD><TD class="col1"> bBSA 0.5 mg/mL, 50 % </TD></TR><TR class="row11"><TD class="col0"> 11 </TD><TD class="col1"> BSA 10 mg/mL </TD></TR></TBODY></TABLE></DIV></DIV><H3 class="sectionedit88">2015.07.02</H3><H4>Experiment/Protocol</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> used slides prepared and spotted on 1.7.2015</DIV></LI><LI class="level1"><DIV class="li"> GFP was taken away from well with pipette and immediately replaced by 10 µl of BSA (10 mg/ml)</DIV></LI><LI class="level1"><DIV class="li"> this step was carried out 2x</DIV></LI><LI class="level1"><DIV class="li"> slides were then washed with PBS from squeeze bottle, the spotting mask was removed and the slides were immediately put into a slideholder filled with 5mg/ml BSA/PBS for ca. 15 min</DIV></LI><LI class="level1"><DIV class="li"> washed slides with aqua <EM>dest</EM> before putting it into the iRIf setup</DIV></LI><LI class="level1"><DIV class="li"> iRIf programm:</DIV></LI><LI class="level2"><DIV class="li"> blocking with 330 µl BSA (5mg/ml in PBS)</DIV></LI><LI class="level2"><DIV class="li"> flushing with 330 µl anti-gfp (5 µg/ml in 5 mg/ml BSA in PBS)</DIV></LI><LI class="level2"><DIV class="li"> flushing with 330 µl streptavidin-cy5 (5 µg/ml in 5 mg/ml BSA in PBS)</DIV></LI></UL></DIV><H4>Results</H4><DIV class="level4"><DIV class="thumb2 trien" style="width:360px"><DIV class="thumbinner"><DIV class="thumbcaption">blocking step iGEM slide</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:360px"><DIV class="thumbinner"><DIV class="thumbcaption">Anti-GFP binding iGEM slide</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:360px"><DIV class="thumbinner"><DIV class="thumbcaption">Strep-Cy5 binding iGEM slide</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:360px"><DIV class="thumbinner"><DIV class="thumbcaption">Strep-Cy5 Fluorescence 100% Laser iGEM slide</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:360px"><DIV class="thumbinner"><DIV class="thumbcaption">Strep-Cy5 Fluorescence 100% Laser Norman slide</DIV></DIV></DIV></DIV><H2 class="sectionedit89">Experiment 23: Second Replicate: Comparison between different GFPs (Own,Max,Weber), replicate 2 of experiment 22</H2><DIV class="level2"><UL><LI class="level1"><DIV class="li"> protocols used :<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/Plasmaactivation" title="protocols:plasma_activation">Plasma activation</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/GOPTS_Surface" title="protocols:gopts_surface">GOPTS surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A></DIV></LI></UL></DIV><H3 class="sectionedit90">2015.07.02</H3><H4>Considerations</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> check reproducibility of strong fluorescence intensities from  experiment 21</DIV></LI></UL></DIV><H4>Experiment/Protocols</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> made 4 GOPTS and 4 APTES/PDITC slides in accordance with the protocols (<A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/GOPTS_Surface" title="protocols:gopts_surface">GOPTS surface</A>, <A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Protocols/APTES_PDITC" title="protocols:aptes_pditc">APTES + PDITC surface</A>)</DIV></LI><LI class="level1"><DIV class="li"> repeated experimental procedure from experiment 21</DIV></LI></UL></DIV><H3 class="sectionedit91">2015.07.03</H3><H4>Experiment/Protocols</H4><DIV class="level4"><UL><LI class="level1"><DIV class="li"> the o/n with GFP, mCherry, etc.incubated slides were used</DIV></LI><LI class="level1"><DIV class="li"> GFP was taken away from well with pipette and immediately replaced by 10 µl of BSA (10 mg/ml)</DIV></LI><LI class="level1"><DIV class="li"> this step was carried out 2x</DIV></LI><LI class="level1"><DIV class="li"> slides were then washed with PBS from squeeze bottle, the spotting mask was removed and the slides were immediately put into a slideholder filled with PBS/BSA for 15 min</DIV></LI><LI class="level1"><DIV class="li"> fluorescence intensity was measured </DIV></LI></UL></DIV><H4>Results</H4><DIV class="level4"><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Evaluation of GOPTS slides</DIV></DIV></DIV><DIV class="thumb2 tcenter" style="width:610px"><DIV class="thumbinner"><DIV class="thumbcaption">Evaluation of PDITC slides</DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>